Calvin B. Harley

Medicine · Health Sciences

57h-index42.1kcitations146works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Telomeres, Telomerase, and Senescence(84), Genetics, Aging, and Longevity in Model Organisms(22), RNA Interference and Gene Delivery(17), Advanced biosensing and bioanalysis techniques(13), DNA Repair Mechanisms(11)

Publications146 total

Data from Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition
2023Open Access
Supplementary Data from Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition
2023Open Access
CCR Translation for This Article from Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition
2023Open Access
Supplementary Data from Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition
2023Open Access
Data from Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition
2023Open Access
CCR Translation for This Article from Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition
2023Open Access
Supplementary Figures 1-5 from The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
2023Open Access
Supplementary Figures 1-5 from The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
2023Open Access
Data from The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
2023Open Access
Supplementary Figure Legends 1-5 from The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
2023Open Access
Supplementary Figure Legends 1-5 from The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
2023Open Access
Data from The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
2023Open Access
Double-Blind, Placebo-Controlled, Randomized Clinical Trial Demonstrates Telomerase Activator TA-65 Decreases Immunosenescent CD8+CD28- T Cells in Humans
OBM Geriatrics·2021· 9 citedOpen Access
Analytical Validation of Relative Average Telomere Length Measurement in a Clinical Laboratory Environment
The Journal of Applied Laboratory Medicine·2017· 2 citedOpen Access
A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study
Rejuvenation Research·2016· 119 citedOpen Access
Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study
Clinical ophthalmology·2016· 56 citedOpen Access
Cycloastragenol Is a Potent Telomerase Activator in Neuronal Cells: Implications for Depression Management
Neurosignals·2014· 82 citedOpen Access
A Natural Product Telomerase Activator as Part of a Health Maintenance Program: Metabolic and Cardiovascular Response
Rejuvenation Research·2013· 94 cited
A Novel Telomerase Activator Suppresses Lung Damage in a Murine Model of Idiopathic Pulmonary Fibrosis
PLoS ONE·2013· 78 citedOpen Access
Astragaloside IV and Cycloastragenol Stimulate the Phosphorylation of Extracellular Signal-Regulated Protein Kinase in Multiple Cell Types
Planta Medica·2011· 45 cited
page 1 of 8Next →

Frequent Co-authors

Richard Allsopp(9), Woodring E. Wright(6), Carol W. Greider(6), Michael D. West(5), Scott L. Weinrich(5), Jerry W. Shay(5), Gregg B. Morin(5), Allison C. Chin(5), Choy‐Pik Chiu(4), William H. Andrews(4), Christopher M. Counter(4), Silvia Bacchetti(4), Sergei Gryaznov(4), Mieczyslaw A. Piatyszek(3), A. B. Futcher(3), Homayoun Vaziri(3), Samuel Goldstein(3), Hal W. Hirte(3), Joseph M. Raffaele(3), Ning Go(3)